Kite's CAR T-cell Therapy Yescarta® First in Europe to Receive Positive CHMP Opinion for Use in Second-line Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma Pharmaceutical Investing
CHMP Adopts Positive Opinion to Extend Indication of Veklury® for the Treatment of Pediatric Patients with COVID-19 Pharmaceutical Investing
WHO Expands Recommendation for Veklury® to Patients With Severe Disease in Latest Update to COVID-19 Guideline Pharmaceutical Investing
Bristol Myers Squibb Announces Adjuvant Treatment with Opdivo Demonstrated Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival in Patients with Stage IIB/C Melanoma in the CheckMate -76K Trial Pharmaceutical Investing
Pfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate in Adolescents Life Science Investing
AbbVie to Present Data from Growing Neuroscience and Movement Disorders Portfolio at 2022 MDS International Congress Pharmaceutical Investing
AbbVie Announces Public Voting Open for 30th Annual Cystic Fibrosis Scholarship "Thriving Student Awards" Pharmaceutical Investing
Pfizer Invites Public to View and Listen to Webcast of Analyst and Investor Call to Review Oral GLP-1 Data Presented at European Association for the Study of Diabetes 2022 Life Science Investing
